Trials / Sponsors / Reviva Pharmaceuticals
Reviva Pharmaceuticals
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia Schizophrenia | Phase 3 | 2022-01-24 |
| Completed | RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder Acute Schizophrenia, Schizoaffective Disorder | Phase 2 | 2011-12-01 |